BIO vs SSSSL
BIO (BIO) versus SuRo Capital Corp. 6.00% Notes due 2026 (SSSSL) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
SuRo Capital Corp. 6.00% Notes due 2026 (SSSSL) common stock listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
SSSSL does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. SSSSL currently screens at market cap $0.
Not investment advice. Open the BIO and SSSSL stock pages for the full models.
Not investment advice.